The misuse of illegal opioids like heroin and fentanyl as well as prescription opioids like oxycodone is discussed in the Opioid Crisis. Pharmaceutical firms started boosting their output of prescription drugs in the 1990s. These businesses urged physicians and other healthcare professionals to boost the prescription of these drugs by stating they were neither addictive or hazardous to patients in order to sell the quantity they were generating. As opposed to therapies like physical therapy, opioids quickly became the most popular approach to treat pain. People started to experience some of the prevalent negative effects of these drugs that pharmaceutical corporations opted not to disclose to medical professionals as they started to rely more and more on prescription opioids to relieve their pain. This caused extraordinarily high overdose rates and death. But the side effects of this excessive medicine persisted. Another unfavourable consequence of prescription drug addiction or overuse is the development of tolerance, which results in these medications no longer producing the same "high" as they previously did. In many cases, this led users to switch to other opioids like heroin and fentanyl, which would have the same effect. This also had a large impact on overdose and fatality rates. The transition to these semi-synthetic and synthetic medicines is seen as the second and third "waves" of the opioid epidemic since they continued to raise the rates of drug usage.
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States